Workflow
Stryker(SYK)
icon
Search documents
Stryker: Rerating Higher
Seeking Alpha· 2024-02-07 13:19
gorodenkoff/iStock via Getty Images Stryker (NYSE:SYK) is a leading medical technology company with a diversified product portfolio. Target markets include orthopedics, spine, surgical instruments, neurotechnology, and medical and surgical equipment. Stryker has a strong position within robotics for orthopedic surgery and is also demonstrating solid growth across its other businesses. While the company's valuation has risen substantially in recent years, this is in response to accelerating growth, impro ...
Stryker declares a $0.80 per share quarterly dividend
Newsfilter· 2024-02-07 13:00
Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers inno ...
Stryker: A Dividend Growth Powerhouse I'd Like To Own
Seeking Alpha· 2024-02-02 13:00
A surgical team works in the operating room. gorodenkoff As an investor, I'm evolving quite a bit after six years of investing with real money. When I first began, I had this slant toward value over growth that was ingrained in me. This pull to value and high yield admittedly cost me capital appreciation on many occasions. In recent years, I have come around a bit more to the mindset that for quality, overpaying in the near term is inevitable. After all, wonderful businesses can make a modest overvaluatio ...
Stryker's (SYK) Q4 Earnings & Revenues Surpass Estimates
Zacks Investment Research· 2024-01-31 16:50
Stryker Corporation (SYK) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $3.46, which beat the Zacks Consensus Estimate of $3.27 by 5.81%. The bottom line also improved 15.3% year over year.GAAP EPS was $2.98, up 102.7% from the year-ago quarter.Price PerformanceSYK’s shares have gained 13.4% in the past six months compared with the industry's gain of 0.8%. The S&P 500 Index increased 7.6% in the same period.Image Source: Zacks Investment ResearchRevenue DetailsRevenues totaled $5.8 billi ...
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
Businesswire· 2024-01-31 13:10
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting, Tampa Bay, Fla., Feb. 1-4 (booth #919). The launch of Prophecy Footprint also coincides with the tenth anniversary of Stryker’s Infinity ...
Stryker(SYK) - 2023 Q4 - Earnings Call Transcript
2024-01-31 02:28
Stryker Corporation (NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ET Company Participants Kevin Lobo – Chair and Chief Executive Officer Jason Beach – Vice President-Investor Relations Glenn Boehnlein – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Lawrence Biegelsen – Wells Fargo Ryan Zimmerman – BTIG Joanne Wuensch – Citi Vijay Kumar – Evercore ISI Shagun Singh – RBC Pito Chickering – Deutsche Bank Travis Steed – Bank of America Matthew O’Brien – Pipe ...
Stryker (SYK) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-01-31 00:36
For the quarter ended December 2023, Stryker (SYK) reported revenue of $5.82 billion, up 11.8% over the same period last year. EPS came in at $3.46, compared to $3.00 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.6 billion, representing a surprise of +3.81%. The company delivered an EPS surprise of +5.81%, with the consensus EPS estimate being $3.27.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates
Zacks Investment Research· 2024-01-30 23:16
Stryker (SYK) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of $3.27 per share. This compares to earnings of $3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.81%. A quarter ago, it was expected that this medical device maker would post earnings of $2.44 per share when it actually produced earnings of $2.46, delivering a surprise of 0.82%.Over the last four quarters, the company h ...
Stryker reports 2023 operating results and 2024 outlook
Newsfilter· 2024-01-30 21:05
Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin of 21.6%Adjusted operating income margin(1) increased 60 bps to 27.2%Reported EPS increased 102.7% to $2.98Adjusted EPS(1) increased 15.3% to $3.46  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Con ...
Countdown to Stryker (SYK) Q4 Earnings: Wall Street Forecasts for Key Metrics
Zacks Investment Research· 2024-01-25 15:20
Wall Street analysts expect Stryker (SYK) to post quarterly earnings of $3.27 per share in its upcoming report, which indicates a year-over-year increase of 9%. Revenues are expected to be $5.6 billion, up 7.7% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead ...